ESC 365 - 10-year outcomes from a randomized comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

ESC Premium Access

10-year outcomes from a randomized comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Session: Outcome of coronary stenting up to 10 years

Topic: Stents

Speaker: Doctor M. Pareek (Copenhagen, DK)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Manan Pareek

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

1 presentation

0 follower

5 more presentations in this session

Differential effectiveness of drug-coated balloon vs. drug-eluting stent for bare-metal or drug-eluting stent restenosis: a primary prespecified subanalysis from the DAEDALUS study.

Speaker: Doctor D. Giacoppo (Catania, IT)

Up to 10-year outcome after simple crossover stenting in left main without strut opening over ostial circumflex artery

Speaker: Doctor Y. Cho (Daegu, KR)

Hybrid coronary revascularization in selected patients with multivessel disease - 5 year clinical outcomes of the prospective randomized pilot study.

Speaker: Doctor M. Tajstra (Zabrze, PL)

Prognosis of biodegradable polymer drug-eluting stents versus second-generation durable polymer drug-eluting stents in acute myocardial infarction patients following percutaneous coronary intervention

Speaker: Doctor J. Choe (Pusan, KR)

Cost-effectiveness analysis of increased use of percutaneous coronary intervention in acute coronary syndrome patients from 6 European countries.

Speaker: Doctor I. Roman Degano (Barcelona, ES)

Access the full session

Outcome of coronary stenting up to 10 years

Speakers: Doctor M. Pareek, Doctor D. Giacoppo, Doctor Y. Cho, Doctor M. Tajstra, Doctor J. Choe...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources